| Unique ID issued by UMIN | UMIN000007292 |
|---|---|
| Receipt number | R000008600 |
| Scientific Title | Effect of mosapride on glycemic control and incretin secretion |
| Date of disclosure of the study information | 2012/02/17 |
| Last modified on | 2012/11/16 10:40:06 |
Effect of mosapride on glycemic control and incretin secretion
Effect of mosapride on incretin secretion
Effect of mosapride on glycemic control and incretin secretion
Effect of mosapride on incretin secretion
| Japan |
Dibetes
| Endocrinology and Metabolism |
Others
NO
To evaluate incretin secretionby the administraton of mosapride
Pharmacodynamics
Plasma glucose, serum insuin and glucagon and plasma incretin levels
Interventional
Factorial
Non-randomized
Open -no one is blinded
Placebo
2
Treatment
| Medicine |
Control: no medication
Mosapride: administration of mosapride
| 20 | years-old | <= |
| Not applicable |
Male and Female
Patients with type 2 diabetes and healthy subjects
taking another medicine to improve gastric movement
40
| 1st name | |
| Middle name | |
| Last name | Kazutaka Aoki |
Yokohama City Unversity
Endocrinology and metabolism
3-9 Fuku-ura, kanazawa-ku,Yokohama
| 1st name | |
| Middle name | |
| Last name |
Yokohama City Unversity
Endocrinology and metabolism
045-787-2800
Yokohama City Unversity
None
Self funding
NO
| 2012 | Year | 02 | Month | 17 | Day |
Unpublished
Completed
| 2011 | Year | 08 | Month | 11 | Day |
| 2013 | Year | 03 | Month | 01 | Day |
| 2012 | Year | 02 | Month | 14 | Day |
| 2012 | Year | 11 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008600